IPHA News

March 2, 2023

IPHA says Ireland should challenge proposals that would degrade investment in medicines in Europe

Annual Conference to assess innovation pipeline and supportive policies Proposals from the European Commission to weaken intellectual property rights will degrade the development and delivery of […]
February 24, 2023

IPHA welcomes Mazars Report as roadmap for faster access to life-changing new medicines

The decision by Minister for Health, Stephen Donnelly T.D. to publish the Mazars Report today has been welcomed by the Irish Pharmaceutical Healthcare Association as a […]
December 5, 2022

Almost half of people unaware what vaccines they can get for adult diseases, says Ipsos survey for IPHA

61% would follow doctor’s advice on vaccination 51% have received two or more booster Covid-19 vaccine doses 77% believe children should study science at school Almost […]
November 7, 2022

New study urges focus on competitiveness as Europe’s medicines innovators face pressure from US and Asia

IPHA urges Government to heed slide in Europe’s research and development investments and clinical trials activity as policymakers in Brussels weigh legislative changes Europe could lose […]
November 4, 2022

Policymakers should heed the shifting landscape for medicines innovation, writes Bernard Mallee

The biopharmaceutical industry is surging. But believing that the surge is permanent, or inevitable, would be a mistake. Like other industries, we are buffeted by international […]
October 20, 2022

Hundreds of cancer deaths could be avoided each year if survival rates matched western European standards, says new study for IPHA

Comparator research, conducted by the Swedish Institute for Health Economics, finds: Cancer survival has improved since the 1990s but demographic pressures could push diagnoses to 42,000 […]
October 10, 2022

Three in five people expect another Covid-19 ‘wave’ this year, says Ipsos survey for IPHA

84% of people believe Ireland would be better prepared for another pandemic due to our experience with Covid-19 Trust in vaccines remains high, with 79% of […]
September 27, 2022

Budget’s €18m for new medicines falls short of amount needed to optimise patients’ access to innovation

Budget’s €18m for new medicines falls short of amount needed to optimise patients’ access to innovation Originator industry acknowledges extraordinary pressures facing the Government but the […]
September 26, 2022

Europe’s planned legislative overhaul is a chance to make our voices count, writes Bernard Mallee

In the coming weeks, the Government will publish a White Paper on Enterprise. It will explore strategic policy options facing the enterprise sector. It comes as […]